fig1
Figure 1. A: Frequency of alterations of PTEN and PIK3CA in breast cancer patients by subtype, analysed using the Pan-cancer Atlas dataset (n = 994) from The Cancer Genome Atlas Program (www.cbioportal.org); B: Signalling crosstalk between the PI3K and MAPK signalling pathways, with examples of targeted inhibitors directed at the network nodes
